French and South Korean Drugmakers Partner to Develop Single-Shot Universal Flu Vaccine

Lyon, Friday, 28 August 2026.
Osivax and GC Biopharma have partnered to co-develop a single-injection flu vaccine offering broader, longer-lasting immunity by targeting both surface and internal viral proteins.